Delord JP - Search Results

1

Late epidermal growth factor receptor inhibitor-related papulopustular rash: a distinct clinical entity.

Sibaud V, Tournier E, Roché H, Del Giudice P, Delord JP, Hubiche T. Sibaud V, et al. Among authors: delord jp. Clin Exp Dermatol. 2016 Jan;41(1):34-7. doi: 10.1111/ced.12675. Epub 2015 May 11. Clin Exp Dermatol. 2016. PMID: 25959005

2

[Primary dural lymphoma: a report of two cases with review of the literature].

Benouaich A, Delord JP, Danjou M, Richaud J, Urocoste E, Soum F, Aziza R, Roche H. Benouaich A, et al. Among authors: delord jp. Rev Neurol (Paris). 2003 Jul;159(6-7 Pt 1):652-8. Rev Neurol (Paris). 2003. PMID: 12910073 Review. French.

3

Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect.

Puisset F, Chatelut E, Sparreboom A, Delord JP, Berchery D, Lochon I, Lafont T, Roché H. Puisset F, et al. Among authors: delord jp. Cancer Chemother Pharmacol. 2007 Jul;60(2):305-8. doi: 10.1007/s00280-006-0385-4. Epub 2006 Nov 24. Cancer Chemother Pharmacol. 2007. PMID: 17124593

4

[Cutaneous side effects associated with epidermal growth factor receptor and tyrosine kinase inhibitors].

Deslandres M, Sibaud V, Chevreau C, Delord JP. Deslandres M, et al. Among authors: delord jp. Ann Dermatol Venereol. 2008 Jan;Spec No 1:16-24. doi: 10.1016/S0151-9638(08)70093-0. Ann Dermatol Venereol. 2008. PMID: 18342113 Review. French.

5

Sorafenib-induced hand-foot skin reaction: a Koebner phenomenon?

Sibaud V, Delord JP, Chevreau C. Sibaud V, et al. Among authors: delord jp. Target Oncol. 2009 Dec;4(4):307-10. doi: 10.1007/s11523-009-0127-8. Epub 2009 Nov 7. Target Oncol. 2009. PMID: 19894099

6

[Dermatologic adverse events of the new targeted anticancer therapies used in oncodermatology].

Sibaud V, Delord JP, Chevreau C, Gangloff D, Garrido-Stowhas I. Sibaud V, et al. Among authors: delord jp. Ann Chir Plast Esthet. 2012 Apr;57(2):106-13. doi: 10.1016/j.anplas.2012.02.002. Epub 2012 Mar 15. Ann Chir Plast Esthet. 2012. PMID: 22425393 Review. French.

7

[Adverse skin reactions induced by BRAF inhibitors: a systematic review].

Sibaud V, Lamant L, Maisongrosse V, Delord JP. Sibaud V, et al. Among authors: delord jp. Ann Dermatol Venereol. 2013 Aug-Sep;140(8-9):510-20. doi: 10.1016/j.annder.2013.02.031. Epub 2013 Jun 19. Ann Dermatol Venereol. 2013. PMID: 24034635 Review. French.

8

T-DM1-related telangiectasias: a potential role in secondary bleeding events.

Sibaud V, Vigarios E, Combemale P, Lamant L, Lacouture ME, Lacaze JL, Dalenc F, Delord JP. Sibaud V, et al. Among authors: delord jp. Ann Oncol. 2015 Feb;26(2):436-7. doi: 10.1093/annonc/mdu533. Epub 2014 Nov 17. Ann Oncol. 2015. PMID: 25403586 Free article. No abstract available.

9

Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors.

Vigarios E, Lamant L, Delord JP, Fricain JC, Chevreau C, Barrés B, Gomez-Roca C, Boulanger M, Sibaud V. Vigarios E, et al. Among authors: delord jp. Br J Dermatol. 2015 Jun;172(6):1680-1682. doi: 10.1111/bjd.13610. Epub 2015 Apr 19. Br J Dermatol. 2015. PMID: 25495246 No abstract available.

10

T-DM1 extravasation: first description.

Sibaud V, Nougarolis S, Borjesson C, Gangloff D, Delord JP, Pompa V, Saintenac D, Roche H. Sibaud V, et al. Among authors: delord jp. J Eur Acad Dermatol Venereol. 2016 Jul;30(7):1235-6. doi: 10.1111/jdv.13164. Epub 2015 Apr 16. J Eur Acad Dermatol Venereol. 2016. PMID: 25879278 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

236 results

Search Page